390 related articles for article (PubMed ID: 23307348)
21. Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.
Bake S; Okoreeh AK; Alaniz RC; Sohrabji F
Endocrinology; 2016 Jan; 157(1):61-9. PubMed ID: 26556536
[TBL] [Abstract][Full Text] [Related]
22. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
23. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.
Zhao YZ; Lin M; Lin Q; Yang W; Yu XC; Tian FR; Mao KL; Yang JJ; Lu CT; Wong HL
J Control Release; 2016 Feb; 224():165-175. PubMed ID: 26774220
[TBL] [Abstract][Full Text] [Related]
24. Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice.
Seo HB; Kang BK; Kim JH; Choi YW; Hong JW; Choi BT; Shin HK
BMC Complement Altern Med; 2015 May; 15():157. PubMed ID: 26012470
[TBL] [Abstract][Full Text] [Related]
25. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Chen D; Lee J; Gu X; Wei L; Yu SP
ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
[TBL] [Abstract][Full Text] [Related]
26. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
Lv W; Xu J; Wang X; Li X; Xu Q; Xin H
ACS Nano; 2018 Jun; 12(6):5417-5426. PubMed ID: 29869497
[TBL] [Abstract][Full Text] [Related]
27. The Janus Face of VEGF in Stroke.
Geiseler SJ; Morland C
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734653
[TBL] [Abstract][Full Text] [Related]
28. Brain Drug Delivery Systems for the Stroke Intervention and Recovery.
Luo T; Wang J; Hao S; Guo T; Ren P; Cheng Z; Gao F; Gong Y; Wang B
Curr Pharm Des; 2017; 23(15):2258-2267. PubMed ID: 27784243
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.
Zhang Y; Pardridge WM
Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502
[TBL] [Abstract][Full Text] [Related]
31. Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.
González-Nieto D; Fernández-Serra R; Pérez-Rigueiro J; Panetsos F; Martinez-Murillo R; Guinea GV
Cells; 2020 Apr; 9(5):. PubMed ID: 32357544
[TBL] [Abstract][Full Text] [Related]
32. Effects of nicorandil on neurobehavioral function, BBB integrity, edema and stereological parameters of the brain in the sub-acute phase of stroke in a rat model.
Owjfard M; Bigdeli MR; Safari A; Namavar MR
J Biosci; 2020; 45():. PubMed ID: 32345775
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
34. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
35. Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats.
Zhao H; Bao XJ; Wang RZ; Li GL; Gao J; Ma SH; Wei JJ; Feng M; Zhao YJ; Ma WB; Yang Y; Li YN; Kong YG
Hum Gene Ther; 2011 Feb; 22(2):207-15. PubMed ID: 21128742
[TBL] [Abstract][Full Text] [Related]
36. Microthrombus-Targeting Micelles for Neurovascular Remodeling and Enhanced Microcirculatory Perfusion in Acute Ischemic Stroke.
Lu Y; Li C; Chen Q; Liu P; Guo Q; Zhang Y; Chen X; Zhang Y; Zhou W; Liang D; Zhang Y; Sun T; Lu W; Jiang C
Adv Mater; 2019 May; 31(21):e1808361. PubMed ID: 30957932
[TBL] [Abstract][Full Text] [Related]
37. XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression.
Qu XY; Zhang YM; Tao LN; Gao H; Zhai JH; Sun JM; Song YQ; Zhang SX
Chin J Nat Med; 2019 Jul; 17(7):498-505. PubMed ID: 31514981
[TBL] [Abstract][Full Text] [Related]
38. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
39. MLC901 Favors Angiogenesis and Associated Recovery after Ischemic Stroke in Mice.
Gandin C; Widmann C; Lazdunski M; Heurteaux C
Cerebrovasc Dis; 2016; 42(1-2):139-54. PubMed ID: 27099921
[TBL] [Abstract][Full Text] [Related]
40. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice.
Kilic U; Kilic E; Dietz GP; Bähr M
Stroke; 2003 May; 34(5):1304-10. PubMed ID: 12677018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
